Tuborg Havnevej 19, Hellerup, Hellerup, DNK
- Novo A/S is a holding company in the Novo Group and is fully owned by the Novo Nordisk Foundation. It is a majority shareholder in Novo Nordisk A/S and Novozymes A/S and manage the Novo Nordisk Foundation's financial assets. Eivind Kolding succeeded Henrik Gürtler as CRO on 1 May 2014.Investments In May 2013, Novo acquired all shares in the pharmaceutical company Xellia.In July 2014, Novo acquired all shares in Sonion, a manufacturer of components for the hearing aid industry.
There is much more to this profile.
Log in or sign up for free to see the whole thing.
Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats